Engineered Veterinary Vectored Immunotherapy and Vaccines: EVVIVAX

Just open a Bet365 account today and make a deposit http://abonuscode.co.uk Make a deposit of £10-£200 and then enter the 10-digit bonus code

Clinical Trials

To meet the need for safer and more effective treatments for canine cancer, EVVIVAX is conducting clinical trials in collaboration with the University of Pisa, Italy and VOS (Veterinary Oncology Service), New York, USA:

Tel-eVax

AAHSD000080
Evaluating a targeted Telomerase vaccine to stimulate anti-tumor immunity and prolong survival times in dogs and cats with various cancers – Species: Canine and Feline

 

Erb-eVax

AAHSD000081
Evaluating a targeted her2/neu cancer vaccine for the stimulation of anti-tumor immunity and prolonging survival times in dogs with osteosarcoma (bone cancer) – Species: Canine

AAHSD000082
Evaluating a targeted her2/neu cancer vaccine for the stimulation of anti-tumor immunity and prolonging survival times in dogs with mammary adenocarcinoma (bone cancer) – Species: Feline

AAHSD000085
Evaluating a targeted her2/neu cancer vaccine for the stimulation of anti-tumor immunity and prolonging survival times in dogs with transitional cell carcinoma (bladder or prostate cancer). Species: Canine

 

Details are available at AVMA Animal Health Studies Database (AAHSD).

 

Additional trials for other cancer types are in development

 

Evvivax News

  • 10-12 Apr 2017

    10-12 Apr 2017 - EVVIVAX at the World Veterinary Vaccine Conference, Washington DC, USA Join us at t...
  • 7 Apr 2017

    7 Apr 2017: EVVIVAX Visiting PennVet, Philadelphia, USA Dr Luigi Aurisicchio, CEO at EVVIVAX and Pre...
  • 10-12 Oct 2016

    Barcelona, 10-12 October 2016: EVVIVAX will be at the World Veterinary Vaccine Meeting
  • 6 Sep 2016

    London, 6 September 2016:EVVIVAX has participated at the meeting "Comparative Oncology: The Next Fro...